Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × OTHER_GOV × CP protocol × Clear all

Phase

Status

Completed 2 Unknown 1 Active not recruiting 1

Sponsor Class

OTHER 8 OTHER_GOV 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 1

Interventions

apatinib 22 Cisplatin 17 Capecitabine 16 Irinotecan 14 Radiotherapy 12 camrelizumab 11 Drug Therapy 11 Cyclophosphamide 11 S 1 (combination) 10 Paclitaxel 10 fludarabine 9 Oxaliplatin 9 Carboplatin 9 Blood Specimen Collection 9 Docetaxel 8 Bevacizumab 8 Nivolumab 7 Erlotinib Hydrochloride 7 tislelizumab 6 Surgical Procedures, Operative 6 Radiation 6 toripalimab 5 XELOX 5 Propranolol 5 Gemcitabine 5 Fluorouracil 5 Exercise 5 Doxorubicin 5 Albumin-Bound Paclitaxel 5 Tamoxifen 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02924909 2018-03-20

QUIMERA

Instituto Nacional de Cancer, Brazil

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡